Market Overview - The Shanghai Composite Index closed at 3968.84 points, with a slight increase of 0.09% [1] - The total trading volume of A-shares reached 2461.743 billion yuan [1] Technical Analysis - A total of 167 A-shares experienced a death cross, where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Sanfu New Science (三孚新科) with a difference of -1.68% [1] - Tianjian Technology (天箭科技) with a difference of -1.66% [1] - Zhongmin Energy (中闽能源) with a difference of -1.30% [1] Individual Stock Performance - Sanfu New Science (688359) decreased by 0.25% with a trading turnover of 1.57% [1] - Tianjian Technology (002977) saw a significant drop of 9.99% with a trading turnover of 2.27% [1] - Zhongmin Energy (600163) declined by 2.17% with a trading turnover of 1.33% [1] - Other notable stocks include: - Hainan Ruize (002596) increased by 0.94% [1] - Weidao Nano (688147) decreased by 1.54% [1] - Eighty Billion (688181) increased by 0.31% [1] Additional Stock Movements - Stocks such as Xiling Information (300588) and Zhaolong Interconnect (300913) also showed minor declines of 0.11% and 1.55% respectively [1] - The performance of ST stocks included: - ST Huaxi (002630) with a decrease of 0.40% [1] - ST Meicheng (300237) with a decline of 1.90% [1]

江苏常青树新材料科技股份有限公司 证券代码：603125 证券简称：常青科技 公告编号：2025-083 江苏常青树新材料科技股份有限公司 关于使用暂时闲置募集资金进行现金管理到期赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏常青树新材料科技股份有限公司（以下简称"公司"）于 2025 年 4 月 11 日召开第二届董事会第十次会议和第二届监事会第九次会议，审议通过《关 于公司拟使用暂时闲置募集资金进行现金管理的议案》，同意使用不超过人民币 55,000.00 万元(含本数）的暂时闲置募集资金进行现金管理，该额度自董事会审 议通过之日起 12 个月内有效。独立董事对该事项召开了独立董事专门会进行讨 论，保荐人发表了无异议的核查意见。 一、使用闲置募集资金进行委托理财到期赎回的情况 江苏常青树新材料科技股份有限公司 近日，公司使用暂时闲置募集资金购买的部分理财产品到期赎回，具体情况 如下： | 序 | 受托方 | 产品名称 | 产品 | 投资金额 | 预计年化 | 产品 期限 | 产品 | 产品 | 实际收益 ...

证券代码：603125 证券简称：常青科技 公告编号：2025-082 江苏常青树新材料科技股份有限公司 关于使用暂时闲置自有资金进行现金管理到期赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏常青树新材料科技股份有限公司（以下简称"公司"）于 2025 年 4 月 11 日召开的第二届董事会第十次会议及第二届监事会第九次会议，审议通过了《关 于公司拟使用暂时闲置自有资金进行现金管理的议案》，同意公司在不超过人民 币 50,000 万元的额度内使用闲置自有资金进行现金管理，上述额度自董事会审 议通过之日起 12 个月内可滚动计算。该事项在董事会审批权限内，无须提交股 东会审议。 一、使用闲置自有资金进行现金管理到期赎回的情况 江苏常青树新材料科技股份有限公司 单位：万元 序 号 受托方 产品 类型 投资金额 收益类型 起息日 到期日 到期 状态 预期年化 收益率 是否 赎回 实际 收益 1. 中国银行镇江 大港支行 结构性 存款 4,900.00 保本最低 收益型 2024.10.15 2024.12.30 已 ...

证券代码：603125 证券简称：常青科技 公告编号：2025-081 江苏常青树新材料科技股份有限公司 关于使用暂时闲置自有资金进行现金管理到期赎回的公告 江苏常青树新材料科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏常青树新材料科技股份有限公司（以下简称"公司"）于 2025 年 4 月 11 日召开的第二届董事会第十次会议及第二届监事会第九次会议，审议通过了《关 于公司拟使用暂时闲置自有资金进行现金管理的议案》，同意公司在不超过人民 币 50,000 万元的额度内使用闲置自有资金进行现金管理，上述额度自董事会审 议通过之日起 12 个月内可滚动计算。该事项在董事会审批权限内，无须提交股 东会审议。 二、截至本公告日，连续 12 个月内滚动使用自有资金现金管理的情况 序 号 受托方 产品名称 产品 性质 投资 金额 （万元） 预计年化 收益率 产品 期限 起息日 到期日 实际 收益 （万元） 1. 江苏银行 镇江大港 支行 对公人民币结构性存 款 2025 年第 40 期 123 天 X 款 保本浮 ...

江苏常青树新材料科技股份有限公司 证券代码：603125 证券简称：常青科技 公告编号：2025-079 江苏常青树新材料科技股份有限公司 关于使用暂时闲置自有资金进行现金管理到期赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏常青树新材料科技股份有限公司（以下简称"公司"）于 2025 年 4 月 11 日召开的第二届董事会第十次会议及第二届监事会第九次会议，审议通过了《关 于公司拟使用暂时闲置自有资金进行现金管理的议案》，同意公司在不超过人民 币 50,000 万元的额度内使用闲置自有资金进行现金管理，上述额度自董事会审 议通过之日起 12 个月内可滚动计算。该事项在董事会审批权限内，无须提交股 东会审议。 | 序 | | | 产品 | 投资 | 预计年化 | 产品 | | | 实际 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | 受托方 | 产品名称 | 性质 | 金额 | 收益率 | 期限 | 起息日 | 到期日 ...

江苏常青树新材料科技股份有限公司 关于使用暂时闲置募集资金进行现金管理到期赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏常青树新材料科技股份有限公司（以下简称"公司"）于 2025 年 4 月 11 日召开第二届董事会第十次会议和第二届监事会第九次会议，审议通过《关 于公司拟使用暂时闲置募集资金进行现金管理的议案》，同意使用不超过人民币 55,000.00 万元(含本数）的暂时闲置募集资金进行现金管理，该额度自董事会审 议通过之日起 12 个月内有效。独立董事对该事项召开了独立董事专门会进行讨 论，保荐人发表了无异议的核查意见。 一、使用闲置募集资金进行委托理财到期赎回的情况 江苏常青树新材料科技股份有限公司 证券代码：603125 证券简称：常青科技 公告编号：2025-080 江苏常青树新材料科技股份有限公司 江苏常青树新材料科技股份有限公司 | 序 | 受托方 | | 产品 | 投资金额 | 收益类型 | 起息日 | 到期日 | 到期 | 预期年化 | 是否 | 实际 | | | | | --- | - ...

每经AI快讯，12月26日，常青科技（603125）公告，公司近日将暂时闲置募集资金购买的理财产品到 期赎回，赎回金额为4900.00万元，赎回时间为2025年12月26日，获得实际收益22.85万元。公司再以 9,900.00万元闲置募集资金进行现金管理。该事项不会影响募集资金投资项目进度和公司正常生产经 营。 ...

Group 1 - The company, Changqing Technology, focuses on the high polymer new materials segment within the fine chemical industry, specializing in special monomers and dedicated additives that enhance the performance and functionality of downstream materials [2] - The downstream applications of the company's products span multiple polymer material processing and manufacturing fields, indicating a wide and diverse range of end-use applications [2] - The application of related products in the M9 resin field depends on the specific production plans and formulation designs of downstream customers, who make autonomous decisions [2] Group 2 - The company aims to leverage its core technological accumulation and diversified product matrix to iteratively upgrade product performance, responding deeply to the customized needs of downstream customers [2] - The company seeks to further consolidate and enhance its differentiated competitive advantage in the high polymer new materials segment [2]

Group 1 - The company has successfully completed the debugging of production processes and equipment for its Phase Seven project, which is now ready for production [2] - The launch of the Phase Seven production line will significantly expand the company's core production capacity, optimize its product matrix structure, and strengthen its competitive position in the key materials sector of the polymer new materials industry [2] - The company is actively engaging in market connections and expanding its customer base related to the Phase Seven project, with plans to disclose relevant order and performance information in accordance with legal and regulatory requirements [2] Group 2 - The company's "Special Polymer Additives and Electronic Materials Manufacturing Project" is progressing as planned, with production lines being completed and gradually put into operation [2] - Some products from this project have already been sent to customers for sampling or have resulted in orders [2]

Group 1 - Rongchang Biotech plans to repurchase shares worth between 20 million and 40 million yuan, with a maximum price of 95 yuan per share, aiming to buy back approximately 21,050 to 42,110 shares, representing about 0.04% to 0.07% of total share capital [1] - Nanya New Materials intends to raise no more than 900 million yuan through a private placement for AI computing power-based high-frequency high-speed copper-clad laminate R&D and working capital [2] - Xiechuang Data has signed a strategic cooperation agreement with Ping An Financial Leasing, aiming for a cooperation scale of 2 billion yuan over three years [3] Group 2 - Chuangshi Technology's controlling shareholder is under investigation and has been placed under detention, having resigned from all positions in the company [4] - Deep Kangjia A has reported overdue shareholder loans to Yikang Technology and Chuzhou Kangxin, totaling approximately 233 million yuan and 395 million yuan respectively, due to repayment issues [5] - Ningbo Yuanyang announced the resignation of two directors due to work adjustments [6] Group 3 - China Merchants Energy has delivered the world's first methanol dual-fuel VLCC oil tanker, with 15 oil tanker orders in hand [7] - Tianyu Co., Ltd. has received a drug registration certificate for hydrochloride trazodone tablets, which are used for treating depression [8] - Haizheng Pharmaceutical has received FDA approval for clinical trials of HS387 tablets for treating advanced solid tumors [9] Group 4 - Warner Pharmaceuticals has obtained a drug registration certificate for isoproterenol hydrochloride injection, used for treating shock and complete atrioventricular block [10] - Hekang New Energy's subsidiary received a government subsidy of 1.5 million yuan, which accounts for 14.57% of the company's latest audited net profit [11] - Duku Culture is planning a change in company control, with stock suspension expected for no more than two trading days [12] Group 5 - Haisco has received acceptance for an IND application for HSK46575 tablets for prostate cancer treatment [13] - *ST Xinyan is executing a capital reserve transfer to increase share capital, resulting in a stock suspension [14] - Nanjing Public Utilities is transferring a 45% stake in a subsidiary for 23.6443 million yuan [15] Group 6 - Action Education plans to repurchase shares worth between 20 million and 25 million yuan, with a maximum price of 45 yuan per share [16] - Bai'ao Tai has received government subsidies totaling 29 million yuan [18] - Weisi Medical intends to sell assets worth 119 million yuan, expecting a profit impact of approximately 10 million yuan [19] Group 7 - Tongyu Communications plans to increase capital by 10 million yuan to introduce investment from Wuchuang Institute [20] - Dongtu Technology's subsidiary is introducing strategic investor Guofeng Investment Fund with a capital increase of 11 million yuan [21] - China General Nuclear Power Technology's shareholder is facing a judicial auction of 2.91% of the company's shares [22] Group 8 - Nanshan Aluminum plans to repurchase shares worth between 300 million and 600 million yuan, with a maximum price of 7.52 yuan per share [23] - Yipin Hong's controlling shareholder has committed to transferring 9.07% equity in Arthrosi without compensation [24] - Sanli Pharmaceutical has signed a technology transfer contract worth 200 million yuan with Hainan University [25] Group 9 - Xin Nuo Wei plans to jointly invest 450 million yuan with Zhongqi Pharmaceutical to establish a joint venture focusing on innovative metabolic drugs [26] - Li Qun Co. has been approved to issue 1 billion yuan in medium-term notes to optimize debt structure and supplement working capital [27] - Dongfang Ocean's subsidiary has received a medical device registration certificate for a procalcitonin test kit [28] Group 10 - Tibet Mining's chairman has resigned due to work adjustments [29] - Wantai Biological's subsidiary has been shortlisted for a national immunization program vaccine procurement project, with a bid price of 27.5 yuan [30] - Xingfu Blue Sea has appointed Zhang Chen as the new deputy general manager [31] Group 11 - Changyuan Donggu has elected Li Yixuan as the vice chairman of the board [32] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuang Robotics for collaboration in humanoid robot development [33] - Yongda Co. has been pre-selected for a procurement project worth approximately 350 million yuan [34] Group 12 - Fuan Pharmaceutical's subsidiary has received a drug registration certificate for hydrochloride trazodone tablets [35] - Nanjing Food reported a 71.03% year-on-year decrease in net profit for November due to rising raw material costs [36] - Changqing Technology's special polymer monomer project has commenced production [37]